[ad_1]
The Coronavac vaccine, from the Chinese laboratory Sinovac, reached 91.25% effectiveness against the coronavirus in phase 3 tests carried out in Turkey, reported this Thursday (12/24) the Chinese newspaper Global Times, indicating as a source the Ministry of Turkish health. .
The vaccine is also being tested in Brazil, in association with the Butantan Institute, which announced on Wednesday (12/23) that the vaccine was effective above the levels required by the National Health Surveillance Agency (Anvisa) and the WHO ( World Organization). Health), but postponed the publication of the results at the request of the Chinese laboratory.
The justification was that the Chinese pharmaceutical Sinovac Biotech, creator of the vaccine, had decided to unify the data of the tests carried out in Brazil, Indonesia and Turkey, which could take 15 days. The Turkish disclosure, however, “punches” the plans.
According to the Butantan Institute and the São Paulo government, the third phase of testing that measured Coronavac’s effectiveness involved 16 research centers in seven states and the Federal District. More than 13 thousand volunteer health professionals participated in the test, among which 170 had some type of contamination, the minimum level is 154.
[ad_2]